Welcome to LookChem.com Sign In|Join Free

CAS

  • or

70799-12-1

Post Buying Request

70799-12-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

70799-12-1 Usage

Description

4-[(Dimethylamino)methyl]phenylboronic acid is a boronic acid derivative with the molecular formula C9H13BNO2. It features a phenyl group with a boronic acid functional group attached, and the presence of a dimethylamino group makes it a versatile ligand in various chemical processes. 4-[(DIMETHYLAMINO)METHYL]PHENYLBORONIC ACID is utilized in organic chemistry, particularly for its role in Suzuki-Miyaura cross-coupling reactions, and is also found in the synthesis of pharmaceuticals and agrochemicals.

Uses

Used in Organic Chemistry:
4-[(Dimethylamino)methyl]phenylboronic acid is used as a reagent in Suzuki-Miyaura cross-coupling reactions for the formation of carbon-carbon bonds. Its unique structure allows for the efficient formation of these bonds, which are crucial in the synthesis of complex organic molecules.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 4-[(Dimethylamino)methyl]phenylboronic acid is used as a key intermediate in the synthesis of various drugs. Its ability to form stable bonds with other molecules makes it a valuable component in the development of new medications.
Used in Agrochemical Synthesis:
Similarly, in the agrochemical industry, 4-[(Dimethylamino)methyl]phenylboronic acid is employed in the synthesis of agrochemicals, such as pesticides and herbicides. Its role in creating stable and effective compounds contributes to the development of more efficient and targeted agricultural products.
Used in Medicinal Chemistry and Drug Development:
Due to its potential as a ligand in catalytic processes, 4-[(Dimethylamino)methyl]phenylboronic acid is studied for its applications in medicinal chemistry. Researchers are exploring its use in the design and development of new drugs, particularly those that require specific binding properties or catalytic activity.

Check Digit Verification of cas no

The CAS Registry Mumber 70799-12-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,7,9 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 70799-12:
(7*7)+(6*0)+(5*7)+(4*9)+(3*9)+(2*1)+(1*2)=151
151 % 10 = 1
So 70799-12-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H14BNO2/c1-11(2)7-8-3-5-9(6-4-8)10(12)13/h3-6,12-13H,7H2,1-2H3

70799-12-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-((Dimethylamino)methyl)phenylboronic acid

1.2 Other means of identification

Product number -
Other names [4-[(dimethylamino)methyl]phenyl]boronic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:70799-12-1 SDS

70799-12-1Downstream Products

70799-12-1Relevant articles and documents

Novel anticancer compound and usage thereof

-

Paragraph 0086; 0087; 0088; 0089, (2019/06/27)

The invention provides a novel anticancer compound. The novel anticancer compound is a compound shown in chemical formula 1 in the description or pharmaceutically acceptable salt of the compound, andthe compound and the salt are active ingredients of a pharmaceutical composition for inhibiting the activity of hepatocyte growth factor receptor (c-Met) tyrosine kinase and pharmaceutical compositionfor preventing or curing excessive or abnormal proliferative diseases. The compound effectively inhibits the activity of the hepatocyte growth factor receptor tyrosine kinase, thereby being suitablefor treating the diseases with the characteristics of excessive or abnormal cell proliferation.

COMPOUNDS

-

Page/Page column 58, (2010/11/26)

A compound of formula (I): compositions and medicaments containing the same as well as processes for the preparation and use of such compounds, compositions and medicaments, particularly in diseases associated with inappropriate Aurora activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 70799-12-1